Retina

241-256 of 338

• 

  RestartResume

  Clinical and Pathological Benefits of Photobiomodulation - Archive

  RestartResume

  Clinical and Pathological Benefits of Photobiomodulation - Archive

  CME/CE Broadcast Replay

  Clinical and Pathological Benefits of Photobiomodulation - Archive

  1.50 credits

  1.50 credits

• 

  RestartResume

  Managing Diabetic Macular Edema: Best Practices in Real-World Situations

  RestartResume

  Managing Diabetic Macular Edema: Best Practices in Real-World Situations

  CME/CE

  Managing Diabetic Macular Edema: Best Practices in Real-World Situations

  Sophie J. Bakri, MD; Peter K. Kaiser, MD

  1.00 credit

  • 

    

    Sophie J. Bakri, MD

  • 

    

    Peter K. Kaiser, MD

  • 

    

    Baruch D. Kuppermann, MD, PhD

  • 

    

    Christina Y. Weng, MD, MBA

  1.00 credit

• 

  RestartResume

  The Business of Medical Retina: Overcoming Payor Challenges

  RestartResume

  The Business of Medical Retina: Overcoming Payor Challenges

  CME/CE

  The Business of Medical Retina: Overcoming Payor Challenges

  David Eichenbaum, MD; Sean Goodale, CPA, MBA

  1.00 credit

  • 

    

    David Eichenbaum, MD

  • 

    

    Sean Goodale, CPA, MBA

  • 

    

    Alison L. Ratliff, MBA

  • 

    

    Ankoor R. Shah, MD

  • 

    

    Nathan Steinle, MD

  1.00 credit

• 

  RestartResume

  Gene Therapy: An Emerging Frontier in the Treatment of Neovascular Diseases

  RestartResume

  Gene Therapy: An Emerging Frontier in the Treatment of Neovascular Diseases

  CME/CE Broadcast Replay

  Gene Therapy: An Emerging Frontier in the Treatment of Neovascular Diseases

  Arshad M. Khanani, MD, MA; Charles C. Wykoff, MD, PhD

  1.25 credits

  • 

    

    Arshad M. Khanani, MD, MA

  • 

    

    Charles C. Wykoff, MD, PhD

  1.25 credits

• 

  RestartResume

  Geographic Atrophy: Expanding Our Understanding of the Disease and its Management

  RestartResume

  Geographic Atrophy: Expanding Our Understanding of the Disease and its Management

  CME/CE Broadcast Replay

  Geographic Atrophy: Expanding Our Understanding of the Disease and its Management

  Rishi P. Singh, MD; Nathan Steinle, MD

  1.25 credits

  • 

    

    Rishi P. Singh, MD

  • 

    

    Nathan Steinle, MD

  • 

    

    Charles C. Wykoff, MD, PhD

  1.25 credits

• 

  RestartResume

  Advances in Sustained-Release Agents for Post-Vitrectomy Pain and Inflammation

  RestartResume

  Advances in Sustained-Release Agents for Post-Vitrectomy Pain and Inflammation

  CME/CE Broadcast Replay

  Advances in Sustained-Release Agents for Post-Vitrectomy Pain and Inflammation

  Marc C. Peden, MD; Ivan J. Suner, MD, MBA

  0.50 credits

  • 

    

    Marc C. Peden, MD

  • 

    

    Ivan J. Suner, MD, MBA

  0.50 credits

• 

  RestartResume

  Beyond the Anti-VEGFs: An Update on Current and Future AMD Treatment Strategies

  RestartResume

  Beyond the Anti-VEGFs: An Update on Current and Future AMD Treatment Strategies

  CME/CE

  Beyond the Anti-VEGFs: An Update on Current and Future AMD Treatment Strategies

  Peter K. Kaiser, MD; Baruch D. Kuppermann, MD, PhD

  1.00 credit

  • 

    

    Peter K. Kaiser, MD

  • 

    

    Baruch D. Kuppermann, MD, PhD

  • 

    

    Jennifer I. Lim, MD

  • 

    

    Jeremy D. Wolfe, MD

  1.00 credit

• 

  RestartResume

  Sustained Delivery of Anti-VEGF Agents: Gene Therapy for the Treatment of Neovascular AMD

  RestartResume

  Sustained Delivery of Anti-VEGF Agents: Gene Therapy for the Treatment of Neovascular AMD

  CME/CE Broadcast Replay

  Sustained Delivery of Anti-VEGF Agents: Gene Therapy for the Treatment of Neovascular AMD

  Arshad M. Khanani, MD, MA; Christina Y. Weng, MD, MBA

  0.75 credits

  • 

    

    Arshad M. Khanani, MD, MA

  • 

    

    Christina Y. Weng, MD, MBA

  0.75 credits

• 

  RestartResume

  Sustained Delivery of Anti-VEGF Agents: The Port Delivery System with Ranibizumab for the Treatment of Neovascular AMD

  RestartResume

  Sustained Delivery of Anti-VEGF Agents: The Port Delivery System with Ranibizumab for the Treatment of Neovascular AMD

  CME/CE Broadcast Replay

  Sustained Delivery of Anti-VEGF Agents: The Port Delivery System with Ranibizumab for the Treatment of Neovascular AMD

  Arshad M. Khanani, MD, MA; Peter A. Campochiaro, MD

  0.75 credits

  • 

    

    Arshad M. Khanani, MD, MA

  • 

    

    Peter A. Campochiaro, MD

  0.75 credits

• 

  RestartResume

  Sustained Delivery of Anti-VEGF Agents: Surgical Videos Highlighting Key Techniques

  RestartResume

  Sustained Delivery of Anti-VEGF Agents: Surgical Videos Highlighting Key Techniques

  CME/CE Broadcast Replay

  Sustained Delivery of Anti-VEGF Agents: Surgical Videos Highlighting Key Techniques

  Arshad M. Khanani, MD, MA

  0.75 credits

  • 

    

    Arshad M. Khanani, MD, MA

  0.75 credits

• 

  RestartResume

  Geographic Atrophy: Expanding Our Understanding of the Disease and its Management LIVE

  RestartResume

  Geographic Atrophy: Expanding Our Understanding of the Disease and its Management LIVE

  CME/CE Broadcast Replay

  Geographic Atrophy: Expanding Our Understanding of the Disease and its Management LIVE

  Rishi P. Singh, MD; Nathan Steinle, MD

  1.25 credits

  • 

    

    Rishi P. Singh, MD

  • 

    

    Nathan Steinle, MD

  • 

    

    Charles C. Wykoff, MD, PhD

  1.25 credits

• 

  RestartResume

  What Have We Learned? Best Practices In The Management of DME Part 2 Live

  RestartResume

  What Have We Learned? Best Practices In The Management of DME Part 2 Live

  CME/CE Broadcast Replay

  What Have We Learned? Best Practices In The Management of DME Part 2 Live

  Sophie J. Bakri, MD; Peter Kaiser, MD

  1.75 credits

  • 

    

    Sophie J. Bakri, MD

  • 

    

    Peter Kaiser, MD

  • 

    

    Baruch D. Kuppermann, MD, PhD

  • 

    

    Christina Y. Weng, MD, MBA

  1.75 credits

• 

  RestartResume

  What Have We Learned? Best Practices In The Management of DME Part 1

  RestartResume

  What Have We Learned? Best Practices In The Management of DME Part 1

  CME/CE Broadcast Replay

  What Have We Learned? Best Practices In The Management of DME Part 1

  Sophie J. Bakri, MD; Peter Kaiser, MD

  1.50 credits

  • 

    

    Sophie J. Bakri, MD

  • 

    

    Peter Kaiser, MD

  • 

    

    Baruch D. Kuppermann, MD, PhD

  • 

    

    Christina Y. Weng, MD, MBA

  1.50 credits

• 

  RestartResume

  The New Normal: Strategies for the Management of DME in the Age of COVID & Beyond

  RestartResume

  The New Normal: Strategies for the Management of DME in the Age of COVID & Beyond

  CME/CE Broadcast Replay

  The New Normal: Strategies for the Management of DME in the Age of COVID & Beyond

  Christina Y. Weng, MD, MBA; Sophie J. Bakri, MD

  1.50 credits

  • 

    

    Christina Y. Weng, MD, MBA

  • 

    

    Sophie J. Bakri, MD

  • 

    

    Maria H. Berrocal, MD

  • 

    

    Sumit Sharma, MD

  1.50 credits

• 

  RestartResume

  The New Normal: Strategies for the Management of DME in the Age of COVID & Beyond- Live

  RestartResume

  The New Normal: Strategies for the Management of DME in the Age of COVID & Beyond- Live

  CME/CE Broadcast Replay

  The New Normal: Strategies for the Management of DME in the Age of COVID & Beyond- Live

  Christina Y. Weng, MD, MBA; Sophie J. Bakri, MD

  1.50 credits

  • 

    

    Christina Y. Weng, MD, MBA

  • 

    

    Sophie J. Bakri, MD

  • 

    

    Maria H. Berrocal, MD

  • 

    

    Sumit Sharma, MD

  1.50 credits

• 

  RestartResume

  What Have We Learned? Best Practices In The Management of DME Part 2

  RestartResume

  What Have We Learned? Best Practices In The Management of DME Part 2

  CME/CE Broadcast Replay

  What Have We Learned? Best Practices In The Management of DME Part 2

  Sophie J. Bakri, MD; Peter Kaiser, MD

  1.50 credits

  • 

    

    Sophie J. Bakri, MD

  • 

    

    Peter Kaiser, MD

  • 

    

    Baruch D. Kuppermann, MD, PhD

  • 

    

    Christina Y. Weng, MD, MBA

  1.50 credits